Cargando…
The impact of COVID‐19 pandemic on pulmonary hypertension: What have we learned?
The coronavirus 2019 disease (COVID‐19) pandemic threatened the Spanish health‐care system. Patients with demanding conditions such as precapillary pulmonary hypertension (PH) faced a potentially severe infection, while their usual access to medical care was restricted. This prospective, unicentric...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537953/ https://www.ncbi.nlm.nih.gov/pubmed/36238968 http://dx.doi.org/10.1002/pul2.12142 |
_version_ | 1784803303396212736 |
---|---|
author | Hinojosa, Williams Cristo‐Ropero, María José Cruz‐Utrilla, Alejandro Segura de la Cal, Teresa López‐Medrano, Francisco Salguero‐Bodes, Rafael Pérez‐Olivares, Carmen Navarro, Begoña Ochoa, Nuria Arribas Ynsurriaga, Fernando Escribano‐Subias, Pilar |
author_facet | Hinojosa, Williams Cristo‐Ropero, María José Cruz‐Utrilla, Alejandro Segura de la Cal, Teresa López‐Medrano, Francisco Salguero‐Bodes, Rafael Pérez‐Olivares, Carmen Navarro, Begoña Ochoa, Nuria Arribas Ynsurriaga, Fernando Escribano‐Subias, Pilar |
author_sort | Hinojosa, Williams |
collection | PubMed |
description | The coronavirus 2019 disease (COVID‐19) pandemic threatened the Spanish health‐care system. Patients with demanding conditions such as precapillary pulmonary hypertension (PH) faced a potentially severe infection, while their usual access to medical care was restricted. This prospective, unicentric study assessed the impact of COVID‐19 on PH patients' outcomes and the operational changes in the PH network. Sixty‐three PH patients (41 pulmonary arterial hypertension [PAH]; 22 chronic thromboembolic pulmonary hypertension [CTEPH]) experienced COVID‐19. Overall mortality was 9.5% without differences when stratifying by hemodynamics or PAH‐risk score. Patients who died were older (73.6 ± 5 vs. 52.2 ± 15.4; p = 0.001), with more comorbidities (higher Charlson index: 4.17 ± 2.48 vs. 1.14 ± 1.67; p = 0.0002). Referrals to the PH expert center decreased compared to the previous 3 years (123 vs. 160; p = 0.002). The outpatient activity shifted toward greater use of telemedicine. Balloon pulmonary angioplasty activity could be maintained after the first pandemic wave and lockdown while pulmonary thromboendarterectomy procedures decreased (19 vs. 36; p = 0.017). Pulmonary transplantation activity remained similar. The COVID‐19 mortality in PAH/CTEPH patients was not related to hemodynamic severity or risk stratification, but to comorbidities. The pandemic imposed structural changes but a planned organization and resource reallocation made it possible to maintain PH patients' care. |
format | Online Article Text |
id | pubmed-9537953 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95379532022-10-12 The impact of COVID‐19 pandemic on pulmonary hypertension: What have we learned? Hinojosa, Williams Cristo‐Ropero, María José Cruz‐Utrilla, Alejandro Segura de la Cal, Teresa López‐Medrano, Francisco Salguero‐Bodes, Rafael Pérez‐Olivares, Carmen Navarro, Begoña Ochoa, Nuria Arribas Ynsurriaga, Fernando Escribano‐Subias, Pilar Pulm Circ Research Articles The coronavirus 2019 disease (COVID‐19) pandemic threatened the Spanish health‐care system. Patients with demanding conditions such as precapillary pulmonary hypertension (PH) faced a potentially severe infection, while their usual access to medical care was restricted. This prospective, unicentric study assessed the impact of COVID‐19 on PH patients' outcomes and the operational changes in the PH network. Sixty‐three PH patients (41 pulmonary arterial hypertension [PAH]; 22 chronic thromboembolic pulmonary hypertension [CTEPH]) experienced COVID‐19. Overall mortality was 9.5% without differences when stratifying by hemodynamics or PAH‐risk score. Patients who died were older (73.6 ± 5 vs. 52.2 ± 15.4; p = 0.001), with more comorbidities (higher Charlson index: 4.17 ± 2.48 vs. 1.14 ± 1.67; p = 0.0002). Referrals to the PH expert center decreased compared to the previous 3 years (123 vs. 160; p = 0.002). The outpatient activity shifted toward greater use of telemedicine. Balloon pulmonary angioplasty activity could be maintained after the first pandemic wave and lockdown while pulmonary thromboendarterectomy procedures decreased (19 vs. 36; p = 0.017). Pulmonary transplantation activity remained similar. The COVID‐19 mortality in PAH/CTEPH patients was not related to hemodynamic severity or risk stratification, but to comorbidities. The pandemic imposed structural changes but a planned organization and resource reallocation made it possible to maintain PH patients' care. John Wiley and Sons Inc. 2022-10-01 /pmc/articles/PMC9537953/ /pubmed/36238968 http://dx.doi.org/10.1002/pul2.12142 Text en © 2022 The Authors. Pulmonary Circulation published by John Wiley & Sons Ltd on behalf of Pulmonary Vascular Research Institute. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Research Articles Hinojosa, Williams Cristo‐Ropero, María José Cruz‐Utrilla, Alejandro Segura de la Cal, Teresa López‐Medrano, Francisco Salguero‐Bodes, Rafael Pérez‐Olivares, Carmen Navarro, Begoña Ochoa, Nuria Arribas Ynsurriaga, Fernando Escribano‐Subias, Pilar The impact of COVID‐19 pandemic on pulmonary hypertension: What have we learned? |
title | The impact of COVID‐19 pandemic on pulmonary hypertension: What have we learned? |
title_full | The impact of COVID‐19 pandemic on pulmonary hypertension: What have we learned? |
title_fullStr | The impact of COVID‐19 pandemic on pulmonary hypertension: What have we learned? |
title_full_unstemmed | The impact of COVID‐19 pandemic on pulmonary hypertension: What have we learned? |
title_short | The impact of COVID‐19 pandemic on pulmonary hypertension: What have we learned? |
title_sort | impact of covid‐19 pandemic on pulmonary hypertension: what have we learned? |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537953/ https://www.ncbi.nlm.nih.gov/pubmed/36238968 http://dx.doi.org/10.1002/pul2.12142 |
work_keys_str_mv | AT hinojosawilliams theimpactofcovid19pandemiconpulmonaryhypertensionwhathavewelearned AT cristoroperomariajose theimpactofcovid19pandemiconpulmonaryhypertensionwhathavewelearned AT cruzutrillaalejandro theimpactofcovid19pandemiconpulmonaryhypertensionwhathavewelearned AT seguradelacalteresa theimpactofcovid19pandemiconpulmonaryhypertensionwhathavewelearned AT lopezmedranofrancisco theimpactofcovid19pandemiconpulmonaryhypertensionwhathavewelearned AT salguerobodesrafael theimpactofcovid19pandemiconpulmonaryhypertensionwhathavewelearned AT perezolivarescarmen theimpactofcovid19pandemiconpulmonaryhypertensionwhathavewelearned AT navarrobegona theimpactofcovid19pandemiconpulmonaryhypertensionwhathavewelearned AT ochoanuria theimpactofcovid19pandemiconpulmonaryhypertensionwhathavewelearned AT arribasynsurriagafernando theimpactofcovid19pandemiconpulmonaryhypertensionwhathavewelearned AT escribanosubiaspilar theimpactofcovid19pandemiconpulmonaryhypertensionwhathavewelearned AT hinojosawilliams impactofcovid19pandemiconpulmonaryhypertensionwhathavewelearned AT cristoroperomariajose impactofcovid19pandemiconpulmonaryhypertensionwhathavewelearned AT cruzutrillaalejandro impactofcovid19pandemiconpulmonaryhypertensionwhathavewelearned AT seguradelacalteresa impactofcovid19pandemiconpulmonaryhypertensionwhathavewelearned AT lopezmedranofrancisco impactofcovid19pandemiconpulmonaryhypertensionwhathavewelearned AT salguerobodesrafael impactofcovid19pandemiconpulmonaryhypertensionwhathavewelearned AT perezolivarescarmen impactofcovid19pandemiconpulmonaryhypertensionwhathavewelearned AT navarrobegona impactofcovid19pandemiconpulmonaryhypertensionwhathavewelearned AT ochoanuria impactofcovid19pandemiconpulmonaryhypertensionwhathavewelearned AT arribasynsurriagafernando impactofcovid19pandemiconpulmonaryhypertensionwhathavewelearned AT escribanosubiaspilar impactofcovid19pandemiconpulmonaryhypertensionwhathavewelearned |